A new diaza-benzofluoranthene derivate as drug

The present invention relates to a new 16-tetrazolyl-eburnamenine of formula (I) or pharmaceutically acceptable salt thereof and/or hydrates and/or solvates thereof. The invention also relates to the pharmaceutical compositions containing the compound of formula (I) or hydrates or solvates thereof a...

Full description

Saved in:
Bibliographic Details
Main Authors GYERTYAN ISTVAN, null, null, KOCSIS PAL, BORZA ISTVAN, LASZY JUDIT, ELES JANOS, TIHANYI KAROLY, BALAZS OTTILIA, HORVATH CSILLA
Format Patent
LanguageEnglish
Hungarian
Published 28.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a new 16-tetrazolyl-eburnamenine of formula (I) or pharmaceutically acceptable salt thereof and/or hydrates and/or solvates thereof. The invention also relates to the pharmaceutical compositions containing the compound of formula (I) or hydrates or solvates thereof as active ingredient. The invention also relates to the synthesis of compounds of formula (I), and the chemical and pharmaceutical manufacture of medicaments containing these compounds, as well as the methods of treatment of mammals - including human - with these compounds. There is still further provided methods for the treatment of neurological, neurodegenerative and psychiatric diseases or conditions as well as comprising the step of administering to human, in need of such treatment and/or prophylaxis a pharmaceutical composition comprising a therapeutically effective amount of compound of formula (I) or pharmaceutically acceptable salts thereof alone or together with at least one and a pharmaceutically acceptable carrier and/or diluent.
Bibliography:Application Number: HUP1100641